Solanezumab is a humanized monoclonal IgG1 antibody that binds to the mid-domain of soluble amyloid _ peptide. Solanezumab has been used in research of Alzheimer's disease (AD) therapy.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.